Dr. Robert G. Molnar, MD

Dr. Molnar practices at The Surgery Center of Flint in Flint, Michigan.

Dr. Molnar's NPI, 1770554248, was assigned on January 31, 2006. Dr. Molnar graduated from University of Toledo College of Medicine and Life Sciences in 1991. Dr. Molnar holds Michigan license RM058005.

Dr. Molnar's primary practice is The Surgery Center of Flint, at 5202 Miller Rd, Flint, MI 48507. The practice phone is (810) 732-7700.

Dr. Molnar's primary practice is The Surgery Center of Flint in Flint, Michigan. Dr. Molnar is also affiliated with McLaren Flint. The medical group on file is Michigan Vascular Center. Dmand AI also links Dr. Molnar to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Molnar practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Molnar's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Molnar is board certified in vascular surgery by the American Board of Surgery. Dr. Molnar is licensed in Michigan.

Dmand AI lists blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), leg revascularization and peripheral vascular disease among the conditions Dr. Molnar treats.

CMS data shows 6,214 Medicare services from Dr. Molnar across 33 procedure codes in 2024, for 801 Medicare patients. Medicare paid $262,054 for them.

CMS counts 801 Medicare patients who saw Dr. Molnar in 2024. The largest group is 75 to 84, with 258 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 4.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Molnar's median patient age at 68, with 42% women.

In 2024, Dr. Molnar wrote 123 Medicare Part D claims for 59 patients. 83% of them were for generic drugs. CMS names the drug for 84 of them, across 3 drugs with 11 or more claims each, at $14,965 in total drug cost. In 2023, CMS named 90 claims across 2 drugs.

Dr. Molnar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of leg revascularization (restoring blood flow) by Dr. Molnar, more than 64% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Molnar, published from 2018 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Michigan. Dr. Molnar's most frequent co-authors are Jeffrey Mark Gauvin, MD, Adam Beck, MD and Caleb Ray Birchler, DO.

Dmand AI links Dr. Molnar to 9 clinical trials, 2 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Carotid Artery Diseases, Arteriovenous Fistula and Carotid Stenosis. Medtronic Endovascular sponsors the most, 2. Open Payments lists research payments to Dr. Molnar that name 1 trial.

CMS Open Payments shows 20 general payments to Dr. Molnar from 15 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 96% of the total. W. L. Gore & Associates, Inc. paid the most, $93. It also lists 5 research payments totaling $13,765 in 2016, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Molnar, most recently CMS Stage 1 2012 in 2011.

Dr. Molnar graduated from University of Toledo College of Medicine and Life Sciences in 1991. Dr. Molnar is a member of ACS and SVS.

Dr. Molnar is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 13. Check the plan with the practice before a visit.